The epidemiology of primary liver cancer in a West German population: the Saarland
- PMID: 3015977
- PMCID: PMC12252681
- DOI: 10.1007/BF00389241
The epidemiology of primary liver cancer in a West German population: the Saarland
Abstract
The present study is based on the data of 321 cases of primary liver cancer (PLC); 225 hepatocellular carcinomas (HCC), 54 cholangiocellular carcinomas (CCC) and 35 unclassified carcinomas autopsied between 1963 and 1982 or reported to the Saarland Cancer Registry between 1967 and 1981. The age standardized incidence rate for the Saarland was determined as 1.1. We noticed an increase in incidence for both HCC and CCC. The HCC rise was based on a significant (p less than 0.05) increase for women. The incidence maximum in the successive birth cohorts is shifting into younger age groups. The highest rates were observed in men and women born between 1900 and 1909. The regional distribution of PLC in the Saarland shows an accumulation in the urban areas. The mean survival time from diagnosis to death was 3.1 months. Prognosis was only influenced by the grade of differentiation. 88.3% of the HCC, but only 28.6% of CCC occurred in cirrhotic livers. Orcein staining of 55 liver specimens showed evidence of previous HBV infection in 12 out of 38 cases of HCC (31.6%) and no evidence of HBVB in the 17 cases of CCC studied.
Similar articles
-
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2. Cochrane Database Syst Rev. 2017. PMID: 28351116 Free PMC article.
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
-
Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis.JAMA Netw Open. 2024 Nov 4;7(11):e2443608. doi: 10.1001/jamanetworkopen.2024.43608. JAMA Netw Open. 2024. PMID: 39504020 Free PMC article.
-
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340. Health Technol Assess. 2007. PMID: 17767898
-
Optimal surveillance intervals for hepatocellular carcinoma screening in cirrhotic patients with hepatitis C infection: a Taiwanese national cohort study.BMC Cancer. 2025 Jul 4;25(1):1141. doi: 10.1186/s12885-025-14551-9. BMC Cancer. 2025. PMID: 40615970 Free PMC article.
Cited by
-
Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.World J Gastroenterol. 2001 Apr;7(2):208-15. doi: 10.3748/wjg.v7.i2.208. World J Gastroenterol. 2001. PMID: 11819762 Free PMC article.
References
-
- Aikat BK, Pathania AGS, Sabarwal SP (1977) “Shikata” cell in liver diseases. Indian J Pathol Microbiol 20:145–150 - PubMed
-
- Bartók I, Reminar E, Tóth J, Duschanek P, Kanyár B (1981) Clinicopathological studies of liver cirrhosis and hepatocellular carcinoma in a general hospital. Hum Pathol 12:794–803 - PubMed
-
- Blumberg BS, London WT (1979) Sex differences in response to hepatitis B virus. Arthritis Rheum 22:1261–1273 - PubMed
-
- Brêchot C (1982) Quel est le rôle du virus de l'hépatite B dans l'apparition des carcinomes hépatocellulaires chez les malades atteints de cirrhose alcooliqui. Gastroenterol Clin Biol 6:727–730 - PubMed
-
- Cohen C, Berson D, Geddes EW (1978) Hepatitis B antigen in black patients with hepatocellular carcinoma. Cancer 41:245–249 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical